Atropos Further Integrates Into Stanford Health Care’s EHR
Real world evidence company Atropos Health said it is further integrating with Stanford Health Care to extend the availability of evidence within the electronic health record.
Atropos Health, already installed inside Stanford Health Care’s firewall, said it will now generate evidence that will help clinicians finalize their encounter notes, including those generated by the hospital’s ambient AI provider, DAX from Microsoft, without having to leave their existing workflow.
Palo Alto, Calif.-based Atropos began as a research project at Stanford Medicine in 2011. The “Green Button” concept aimed to answer the question: What if pressing a virtual button could trigger a search of millions of similar, anonymized electronic records to instantly aggregate data to inform patient care?
The concept grew into a research project called the Clinical Informatics Consult service, with a proof of concept built at Stanford Health Care. Upon the successful completion of the pilot, Saurabh Gombar, Nigam Shah, and Brigham Hyde founded Atropos Health in late 2020 to democratize access to real-world evidence. It completed a seed funding round in the fall of 2020, by a group of institutional and individual investors including the Boston Millennia Founders Fund.
In 2021, Stanford Health Care partnered with Atropos to support clinical decision-making across its more than 2,000 affiliated physicians.
With the newly announced deeper integration, Stanford is leveraging Atropos Health’s evidence generation platform and AI technology to answer clinical questions with real world evidence before the question is asked. The pilot will evaluate provider satisfaction, including time savings and use of RWE for treatment decisions. Stanford’s clinicians already rely on the Atropos Green Button for RWE delivered in less than 48 hours and ChatRWD, a generative AI application to deliver full observational studies in minutes.
"The key to maximizing the value of technology is to make seamless integrations that reduce friction on provider workflows,” said Brigham Hyde, M.D., CEO and co-founder at Atropos Health, in a statement. "Integrating personalized evidence from Atropos Health with ambient AI and the EHR demonstrates Stanford’s commitment to adopting solutions that improve clinician satisfaction and drive better outcomes. This takes us one step closer to realizing the dream of personalized care and the Learning Health system while also maximizing convenience and workflow for physicians."
“Over our multi-year collaboration with Atropos Health, we’ve seen significant benefit when it comes to advancing research and providing evidence-based medicine at the bedside,” said Michael Pfeffer, senior vice president and chief information and digital officer for Stanford Medicine, in a statement. “We are seeing additional opportunities to leverage AI-enabled technology to ultimately benefit patients through personalized medicine with this program.”
This announcement follows Atropos Health’s collaboration with Ontada, a McKesson business working in community oncology RWD, clinical education, and point-of-care technologies. The companies said the collaboration would enhance the use cases for clinicians, researchers, and healthcare leaders to design care protocols, advance precision medicine and develop new treatments in oncology.
In 2022 the American Society of Clinical Oncology’s CancerLinQ announced it was partnering with Atropos Health in an effort to provide oncology clinicians with the latest real-world evidence available to help inform personalized care and treatment of an individual patient.
Healthcare Innovation recently interviewed Emory Healthcare's Collin Lee, PharmD, director of clinical pharmacy services, about its work with Atropos on some use cases around medication formulary design and protocols.
